Akynzeo IV 235 mg / 0.25 mg, Konzentrat zur Herstellung einer Infusionslösung
7680682900015
CH-68290
Konzentrat
Associated product:
AKYNZEO IV conc perf 235mg/0.25mg flac 20 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
235.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
197.5 MG | Substance | WIZUS |
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
24.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 100.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2024
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 68290
- Drug name
- Akynzeo IV, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- A04AA55
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 01/09/2022
- Authorization expiration date
- 31/08/2027
- IT Number
- 01.09.0.
- Domain
- Human medicine
Package details
- Description (FR)
- AKYNZEO IV conc perf 235mg/0.25mg flac 20 ml
- Description (DE)
- AKYNZEO IV Inf Konz 235mg/0.25mg Durchstf 20 ml
- Market launch
- 01/09/2022
- Narcotic (BTM)
- No